IDENTIFICATION OF RESPONDER AND DISEASE ACTIVITY THRESHOLDS FOR THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM TWO PHASE 3 TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS

被引：1
|
作者：
Gossec, L. [1 ,2 ]
Coates, L. [3 ]
Orbai, A. M. [4 ]
De Wit, M. [5 ]
Pelligra, C. [6 ]
Lambert, J. [7 ]
Ciaravino, V. [7 ]
Ink, B. [8 ]
Taieb, V. [7 ]
Gladman, D. D. [9 ]
机构：
[1] Sorbonne Univ, Paris, France
[2] Hop La Pitie Salpetriere, AP HP, Paris, France
[3] Univ Oxford, Nuffield Dept Orthopaed, Rheumatol & Musculoskeletal Sci, Oxford, England
[4] Johns Hopkins Univ, Div Rheumatol, Sch Med, Baltimore, MD USA
[5] Stichting Tools, Amsterdam, Netherlands
[6] Evidera, Medellin, Colombia
[7] UCB Pharma, Colombes, France
[8] UCB Pharma, Slough, Berks, England
[9] Univ Toronto, Schroeder Arthrit Inst, Krembil Res Inst, Toronto Western Hosp, Toronto, ON, Canada
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Psoriatic arthritis; Clinical trials; Patient reported outcomes; OUTCOME MEASURE; VALIDATION;
D O I：
10.1136/annrheumdis-2023-eular.1980
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0590-HP
引用
收藏
页码：565 / 566
页数：2
相关论文
共 50 条
  • [41] Psoriatic Arthritis Impact of Disease (PsAID12) Was Provisionally Endorsed at Omeract 2018 As Core Instrument to Measure Psoriatic Arthritis-Specific Health-Related Quality of Life in Randomized Controlled Trials and Longitudinal Observational Studies
    Holland, Richard
    Christensen, Robin
    Goel, Niti
    Hoejgaard, Pil
    Tillett, William
    Gossec, Laure
    de Wit, Maarten
    McHugh, Neil
    Mease, Philip J.
    Shea, Beverly
    Leung, Ying Ying
    Gladman, Dafna D.
    Lindsay, Christine
    Coates, Laura C.
    Ogdie, Alexis
    Strand, Vibeke
    Fallon, Lara
    Birt, Julie
    Duffin, Kristina Callis
    FitzGerald, Oliver
    Tugwell, Peter
    Beaton, Dorcas
    Orbai, Ana-Maria
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [42] Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Coates, Laura
    Bushmakin, Andrew
    FitzGerald, Oliver
    Gladman, Dafna
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Helliwell, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [43] BIMEKIZUMAB REDUCED PSORIATIC ARTHRITIS IMPACT IN PATIENTS WITH PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Gossec, Laure
    Gladman, Dafna D.
    Gisondi, Paolo
    de Wit, Maarten
    Ogdie, Alexis
    Ink, Barbara
    Taieb, Vanessa
    Lambert, Jeremy
    Coates, Laura C.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [44] PATIENT CLUSTERS IDENTIFIED BY MACHINE LEARNING: DATA FROM A POOLED ANALYSIS OF PHASE-3 TRIALS OF SECUKINUMAB IN PSORIATIC ARTHRITIS, ANKYLOSING SPONDYLITIS AND PSORIATIC ARTHRITIS WITH AXIAL MANIFESTATIONS
    Baraliakos, X.
    Pournara, E.
    Gladman, D. D.
    Mease, P. J.
    Jahandideh, S.
    Coates, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 879 - 879
  • [45] INVESTIGATING THE RELATIONSHIP BETWEEN DAILY DISEASE IMPACT SCORES AND MOOD IN PATIENTS WITH PSORIATIC ARTHRITIS USING A SMARTPHONE APPLICATION: A NOVEL USE OF THE PsAID-9 QUESTIONNAIRE
    McGagh, Dylan
    McGowan, Niall
    Wu, Yuhao
    Hinds, Chris
    Saunders, Kate E. A.
    Coates, Laura C.
    RHEUMATOLOGY, 2023, 62
  • [46] Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
    Mease, Philip J.
    Merola, Joseph F.
    Tanaka, Yoshiya
    Gossec, Laure
    Mcinnes, Iain B.
    Ritchlin, Christopher T.
    Landewe, Robert B. M.
    Asahina, Akihiko
    Ink, Barbara
    Heinrichs, Andrea
    Bajracharya, Rajan
    Shende, Vishvesh
    Coarse, Jason
    Coates, Laura C.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1363 - 1382
  • [47] IMPACT OF PERIPHERAL ARTHRITIS ON DISEASE ACTIVITY OUTCOMES IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS, PERIPHERAL SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS - DATA FROM THE ASASPERSPA STUDY
    Lopez-Medina, C.
    Ramiro, S.
    Capelusnik, D.
    Molto, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 53 - 53
  • [48] Bimekizumab impact on core Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) domains for patients with psoriatic arthritis: 52-week results from four phase 3 studies
    Merola, J. F.
    Mease, P. J.
    Deodhar, A.
    Ink, B.
    Fleurinck, C.
    Bajracharya, R.
    Coarse, J.
    Coates, L. C.
    SWISS MEDICAL WEEKLY, 2024, 154 : 36S - 36S
  • [49] Bimekizumab Impact on Core Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Domains for Patients with Psoriatic Arthritis: 52-Week Results from Four Phase 3 Studies
    Merola, Joseph
    Mease, Philip J.
    Deodhar, Atul
    Ink, Barbara
    Fleurinck, Carmen
    Bajracharya, Rajan
    Coarse, Jason
    Coates, Laura
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2819 - 2823
  • [50] Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona Registries
    Mease, Philip J.
    Liu, Mei
    Rebello, Sabrina
    Kang, Hyungjoo
    Yi, Esther
    Park, Yujin
    Greenberg, Jeffrey D.
    RHEUMATOLOGY AND THERAPY, 2019, 6 (04) : 529 - 542
12345